EOCN · Galmed Pharmaceuticals Ltd. · Financials
Market Cap
$4.95M
Shares
1.07M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$0
FY2020
Net Income
-$10.31M
-37.1%
FY2025
Operating Margin
-525.76%
+613.8pp
FY2018
Diluted EPS
$2.39
-70.4%
FY2025
Operating Cash Flow
-$6.32M
-7.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | $0 | $0 | $2.04M | $1.09M | $467K | $0 | $0 | — | — | |
| — | $4.87M | $2.98M | $3.57M | $13M | $27.22M | $26.08M | $18.18M | $8.31M | $9.65M | $14.27M | $7.63M | $6.66M | $7.21M | $2.44M | |
| — | $3.64M | $3.3M | $3.92M | $4.66M | $5.66M | $4.13M | $4.2M | $4.44M | $3.8M | $3.08M | $3.25M | $2.48M | $7.36M | $694K | |
| — | — | $83K | $31K | $35K | $42K | $39K | $35K | $387K | $239K | $169K | $50K | $9000 | $4000 | $5000 | |
| — | $8.51M | $6.28M | $7.49M | $17.65M | $32.88M | $30.21M | $22.38M | $10.72M | $12.36M | $16.88M | $10.88M | $9.14M | $14.57M | $3.14M | |
| — | — | — | — | — | — | -$30.21M | -$22.38M | -$10.72M | -$12.36M | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | -525.76% | -1139.54% | — | — | — | — | — | |
| — | — | — | — | — | — | -$30.17M | -$22.34M | -$10.33M | -$12.13M | — | — | — | — | — | |
| — | -$741K | -$516K | -$580K | -$215K | $414K | $1.44M | -$1.92M | $934K | $65K | $35K | $253K | $40K | -$2.91M | -$6000 | |
| — | — | $7000 | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | $7.52M | $6.91M | $17.87M | -$32.47M | -$28.77M | -$20.46M | -$9.78M | -$12.3M | -$16.85M | -$10.62M | -$9.1M | -$17.48M | -$3.14M | |
| — | $0 | — | — | — | — | $0 | $0 | $75K | $0 | $106K | $0 | $1000 | $1000 | $6000 | |
| -$11.34M | -$10.31M | -$7.52M | -$6.91M | -$17.87M | -$32.47M | -$28.77M | -$20.46M | -$9.86M | -$12.3M | -$16.95M | -$10.62M | -$9.1M | -$17.49M | -$3.15M | |
| — | — | — | — | — | — | — | — | -483.61% | -1133.55% | -3630.19% | — | — | — | — | |
| — | — | — | — | — | — | -$28.53M | -$20.42M | -$9.86M | -$12.22M | -$16.83M | -$10.83M | -$9.1M | -$17.49M | -$3.15M | |
| USD/shares | — | $2.39 | $8.08 | $30.00 | $127.80 | $19.80 | $1.35 | $0.97 | — | — | — | — | — | — | — |
| USD/shares | — | $2.39 | $8.08 | $30.00 | $127.80 | $19.80 | — | — | — | — | — | — | — | — | — |
| shares | — | 4.31M | 930.82K | 230.8K | 139.68K | 1.64M | 21.28M | 21.11M | 18.14M | 12.49M | 11.37M | 11.1M | 10.32M | 5.07M | 4.96M |
| shares | — | 4.31M | 930.82K | 230.8K | 139.68K | 1.64M | 21.28M | 21.11M | 18.14M | 12.49M | 11.37M | 11.1M | 10.32M | 5.07M | 4.96M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.